Global Monkeypox Vaccine And Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Monkeypox Vaccine And Treatment Market Research Report 2024
The JYNNEOS vaccine is approved for prevention of smallpox and monkeypox. It is the primary vaccine being used during this outbreak in the U.S. The ACAM2000 vaccine is an alternative to JYNNEOS. It is also approved to help protect against smallpox and monkeypox.
According to Mr Accuracy reports’s new survey, global Monkeypox Vaccine And Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monkeypox Vaccine And Treatment market research.
Key companies engaged in the Monkeypox Vaccine And Treatment industry include Bavarian Nordic, SIGA Technologies, Chimerix, EMERGENT and Gilead Sciences, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Monkeypox Vaccine And Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Monkeypox Vaccine And Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Monkeypox Vaccine And Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bavarian Nordic
SIGA Technologies
Chimerix
EMERGENT
Gilead Sciences, Inc.
Segment by Type
Vaccine
Drugs
Vaccinia Immune Globulin (VIG)
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monkeypox Vaccine And Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Monkeypox Vaccine And Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monkeypox Vaccine And Treatment market research.
Key companies engaged in the Monkeypox Vaccine And Treatment industry include Bavarian Nordic, SIGA Technologies, Chimerix, EMERGENT and Gilead Sciences, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Monkeypox Vaccine And Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Monkeypox Vaccine And Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Monkeypox Vaccine And Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bavarian Nordic
SIGA Technologies
Chimerix
EMERGENT
Gilead Sciences, Inc.
Segment by Type
Vaccine
Drugs
Vaccinia Immune Globulin (VIG)
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monkeypox Vaccine And Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source